The use of urea for skin barrier correction
- Authors: Albanova V.I.1, Kalinina O.V.2,3, Petrova S.Y.4,5
-
Affiliations:
- Moscow Regional Scientific Research Clinical Institute named after MF Vladimirsky
- Smolensk State Medical University
- Skin and Venereal Diseases Dispensary
- Joint-stock company Pharmaceutical enterprise “Retinoids”
- Mechnikov Research Institute of Vaccines and Sera
- Issue: Vol 98, No 4 (2022)
- Pages: 67-75
- Section: GUIDELINES FOR PRACTITIONERS
- URL: https://journals.rcsi.science/0042-4609/article/view/117634
- DOI: https://doi.org/10.25208/vdv1329
- ID: 117634
Cite item
Full Text
Abstract
The review summarizes information about the main causes and pathogenesis of xerosis cutis as one of the conditions indicating a violation of the epidermal barrier. Xerosis cutis is a clinical sign of a decrease in the amount and/or quality of lipids and/or hydrophilic substances in the stratum corneum of the epidermis. The modern approach to the treatment of dermatoses accompanied by violations of the epidermal barrier includes basic moisturizers. Urea not only moisturizes the skin. It is involved in the regulation of barrier function and antimicrobial protection. It is a low-molecular regulator of protein synthesis in keratinocytes, such as filaggrin, loricrin, involucrin and transglutaminase 1, cathelicidin, beta-defensin-2, water and urea carrier proteins into the cell, as well as proteins that promote the synthesis of intercellular matrix lipids. The main dermatotropic pharmacological effects of urea (hydration of the epidermis, strengthening of the barrier function of the skin, keratolytic effect, increased penetration of drugs into the skin) have been used in dermatological practice for many years. External agents with urea are used to treat skin diseases accompanied by dryness and excessive keratinization, to correct the deformation of nail plates of various genesis, to facilitate the local penetration of medicines. The use of topical UrocrEM5, UrocrEM10, Uroderm ointments containing 5%, 10% and 30% urea, respectively, is effective and safe.
Full Text
##article.viewOnOriginalSite##About the authors
Vera I. Albanova
Moscow Regional Scientific Research Clinical Institute named after MF Vladimirsky
Email: albanova@rambler.ru
ORCID iD: 0000-0001-8688-7578
SPIN-code: 5548-5359
MD, Dr. Sci. (Med.), Professor
Russian Federation, 61/2, bldg 1, Shepkina str, Moscow, 129110Olesya V. Kalinina
Smolensk State Medical University; Skin and Venereal Diseases Dispensary
Email: olesya.kalinina577@yandex.ru
ORCID iD: 0000-0002-1051-4385
SPIN-code: 7783-5990
MD, Cand. Sci. (Med.)
Russian Federation, 28, Krupskaya str., Smolensk, 214019; 16a, Rylenkova str., Smolensk, 214031Stanislava Yu. Petrova
Joint-stock company Pharmaceutical enterprise “Retinoids”; Mechnikov Research Institute of Vaccines and Sera
Author for correspondence.
Email: petrovastanislava@yandex.ru
ORCID iD: 0000-0003-3034-0148
SPIN-code: 7268-6944
MD, Cand. Sci. (Med.)
Russian Federation, 1a, Svobody str., Balashikha, 143983; 5a, Maly Kazenny Pereulok, Moscow, 105064References
- Friedman AJ, von Grote EC, Meckfessel MH. Urea: a clinically oriented overview from bench to bedside. J Drugs Dermatol. 2016;15(5):633–639.
- Verzì AE, Musumeci ML, Lacarrubba F, Micali G. History of urea as a dermatological agent in clinical practice. Int J Clin Pract. 2020;74(187):e13621. doi: 10.1111/ijcp.13621
- Celleno L. Topical urea in skincare: a review. Dermatol Ther. 2018;31(6):e12690. doi: 10.1111/dth.12690
- Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatol Online J. 2013;19(11):20392.
- Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P. Diagnosis and treatment of xerosis cutis — a position paper. J Dtsch Dermatol Ges. 2019;17(7):3–33. doi: 10.1111/ddg.13906
- Garibyan L, Chiou AS, Elmariah SB. Advanced aging skin and itch: addressing an unmet need. Dermatologic Therapy. 2013;26(2):92–103. doi: 10.1111/dth.12029
- Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ, Szepietowski JC. International forum for the study of itch special interest group scoring itch in clinical trials. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the study of itch (IFSI) special interest group scoring itch in clinical trials. Acta Derm Venereol. 2013;93:509–514. doi: 10.2340/00015555-1620
- Thyssen JP, Johansen JD, Zachariae C, Menné T, Linneberg A. Xerosis is associated with atopic dermatitis, hand eczema and contact sensitization independent of filaggrin gene mutations. Acta Derm Venereol. 2013;6;93(4):406–411. doi: 10.2340/00015555-1539
- Augustin M, Kirsten N, Körber A, Wilsmann-Theis D, Itschert G, Staubach-Renz P, Maul JT, Zander N. Prevalence, Predictors and comorbidity of dry skin in the general population. J Eur Acad Dermatol Venereol. 2019;33(1):147–150. doi: 10.1111 / jdv.15157
- Keller BP, Wille J, van Ramshorst B, van der Werken C. Pressure ulcers in intensive care patients: a review of risks and prevention. Intensive Care Med. 2002;28(10):1379–1388. doi: 10.1007/s00134-002-1487
- Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739–751. doi: 10.1038/s41577-021-00538-7
- Évora AS, Adams MJ, Johnson SA, Zhang Z. Corneocytes: Relationship between structural and biomechanical properties. Skin Pharmacol Physiol. 2021;34(3):146–161. doi: 10.1159/000513054
- Хлебникова А.Н., Петрунин Д.Д., Молочков А.В. Липиды человеческого эпидермиса (фундаментальные сведения и клиническая имплементация). М: МОНИКИ; 2015. С. 4–56 [Hlebnikova AN, Petrunin DD, Molochkov AV. Lipids of the human epidermis (fundamental information and clinical implementation). Moscow: MONIKI; 2015:4–56 (In Russ.)].
- Альбанова В.И., Пампура А.Н. Атопический дерматит. М: ГЭОТАР-Медиа; 2020. С. 5–16 [Albanova VI, Pampura AN. Atopic dermatitis. Moscow: GEOTAR-Media; 2020: 5–16 (In Russ.)]. doi: 10.33029/9704-5640-8-ATTI-2020-1-144
- Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771–788. doi: 10.2165/00128071-200304110-00005
- Buraczewska I, Berne B, Lindberg M, Törmä H, Lodén M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol. 2007;156(3):492–498. doi: 10.1111/j.1365-2133.2006.07685.x.3
- Scheinfeld NS. Urea: a review of scientific and clinical data. Skinmed. 2010;8(2):102–6.
- Eberting CL, Coman G, Blickenstaff N. Repairing a compromised skin barrier in dermatitis: leveraging the skin’s ability to heal itself. J Allergy Ther. 2014;5:187. doi: 10.4172/2155-6121.1000187
- Jokura Y, Ishikawa S, Tokuda H, Imokawa G. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J Invest Dermatol. 1995;104(5):806–812. doi: 10.1111/1523-1747.ep12607005
- Lefèvre-Utile A, Braun C, Haftek M, Aubin F. Five functional aspects of the epidermal barrier. Int J Mol Sci. 2021;22(21):11676. doi: 10.3390/ijms222111676
- Альбанова В.И., Петрова С.Ю. Атопический дерматит: Учебное пособие для врачей. М.: ГЭОТАР-Медиа; 2022. с. 133–142 [Albanova VI, Petrova SYu. Atopic dermatitis. Moscow: GEOTAR-Media; 2022:133–142 (In Russ.)]. doi: 10.33029/9704-6852-4-ATD-2022-1-168
- Loden M. The clinical benefit of moisturizers. J. Eur. Acad. Dermatol. Venereol. 2005;19:672–88. doi: 10.1111/j.1468-3083.2005.01326.x
- Аничков Н.М., Сыдиков А.А., Чупров И.Н., Заславский Д.В., Насыров Р.А. Роль межклеточных щелевидных контактов (коннексинов) в патогенезе эритродермий. Архив патологии. 2018;80(4):61–64 [Anichkov NM, Sydikov AA, Chuprov IN, Zaslavskiy DV, Nasyrov RA. Role of intercellular slit-like contacts (connexins) in the pathogenesis of erythroderma. Arkhiv Patologii. 2018;80(4):61–64. (In Russ.)]. doi: 10.17116/patol201880461
- Grice EA. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease. Seminars in cutaneous medicine and surgery. 2014;33(2):98–103. doi: 10.12788/j.sder.0087
- Kraft N, Lynde CW. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett. 2005:10;1–8.
- Sethi A, Kaur T, Malhotra SK, Gambhir ML. Moisturizers: the slippery road. Indian J Dermatol. 2016:61(3);279–287. doi: 10.4103/0019-5154.182427
- Voegeli D. Urea creams in skin conditions: composition and outcomes. Dermatolgy in practice. 2012;18(3):13–5.
- Белоусова Т.А., Гузев К.С., Лаврик О.И., Ноздрин В.И. «Уродерм» (мазь с мочевиной 30%). М.: АО «Ретиноиды»; 2015. С. 1–184 [Belousova TA, Guzev KS, Lavrik OI, Nozdrin VI. “Uroderm” (ointment with urea 30%). Moscow: “Retinoids”; 2015:1–184 (In Russ.)].
- Piquero-Casals J, Morgado-Carrasco D, Granger C, Trullàs C, Jesús-Silva A, Krutmann J. Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties. Dermatol Ther (Heidelb). 2021;11:1905–1915. doi: 10.1007/s13555-021-00611-y
- Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, Jaenicke T, Rodriguez-Martin M, Trullas C, Hupe M, Elias PM, Krutmann J. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol. 2012;132(6):1561–1572. doi: 10.1038/jid.2012.42
- Björklund S, Engblom J, Thuresson K, Sparr E. Glycerol and urea can be used to increase skin permeability in reduced hydration conditions. Eur J Pharm Sci. 2013;50(5):638–645. doi: 10.1016/j.ejps.2013.04.022
- Berardesca E, Cameli N. Non-invasive assessment of urea efficacy: A review. Int J Clin Pract. 2020;74(187):e13603. doi: 10.1111/ijcp.13603
- Starace M, Alessandrini A, Piraccini BM. Clinical evidences of urea at high concentration on skin and annexes. Int J Clin Pract. 2020;74(187):e 13740. doi: 10.1111/ijcp.13740
- Hutchens TW, Li CM, Besch PK. Urea-induced transformation of native estrogen receptor and evidence for separate DNA-and ATP-binding sites. Biochem Biophys Res Commun. 1986;139(3):1250–1255. doi: 10.1016/s0006-291x(86)80312
- van Zuuren EJ, Fedorowicz Z, Arents BWM. Emollients and moisturizers for eczema: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2017;177(5):1256–1271. doi: 10.1111/bjd. 15602
- Lindh JD, Bradley M. Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: a systematic review. Am J Clin Dermatol. 2015;16(5):341–359. doi: 10.1007/s40257-015-0146-4
- Benintende C, Boscaglia S, Dinotta F, Lacarrubba F, Micali G. Treatment of ichthyosis vulgaris with a urea‐based emulsion: videodermatoscopy and confocal microscopy evaluation. G Ital Dermatol Venereol. 2017;152(6):555–559. doi: 10.23736/S0392-0488.17.05743-1
- Клинические рекомендации. Ихтиоз. Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов». 2020. (03 Мая 2022) [Klinicheskie rekomendacii. Ihtioz. RODVK. 2020. (In Russ.)] https://cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020/files/Ихтиоз%2008.10.2020.docx (03 May 2022)
- Охлопков В.А., Комаровский И.В., Скальский С.В. Мочевина — «золотой стандарт» терапии ксероза кожи. Клиническая дерматология и венерология. 2020;19(1):93-100 [Okhlopkov VA, Komarovsky IV, Skalskiy SV. Urea — the gold standard for skin xerosis therapy. Klinicheskaya Dermatologiya i Venerologiya. 2020;19(1):93–100. (In Russ.)]. doi: 10.17116/klinderma20201901193
- Dirschka Т. Mode of action of urea. Int J Clin Pract. 2020;74(187):e13569. doi: 10.1111/ijcp.13569
Supplementary files
